Chronic Lung Disease of Prematurity Withdrawn Phase 3 Trials for Azithromycin (DB00207)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02282176TINN2: Treat Infection in NeoNates 2Prevention